CRANBURY, N.J.--(BUSINESS WIRE)--Physicians’ Education Resource® (PER®), a leading resource for continuing medical education (CME), will host three CME-accredited satellite symposia during the 36th Annual Miami Breast Cancer Conference®. These programs will be held at the Fontainebleau Miami Beach in Florida.
“We look forward to providing three additional educational activities to all our attendees at this year’s 36th Annual Miami Breast Cancer Conference®,” said Phil Talamo, president of PER®. “During these sessions, we encourage our audience members to share questions from their own experiences with our faculty experts, to further promote engagement, so we can improve treatment and management outcomes for patients with breast cancer.”
The PER® satellite symposia are:
- Curbing the Opioid Epidemic: Taking Steps to Improve Postsurgical Outcomes for Your Patients With Breast Cancer, which will be held on Thursday, March 7, from 7:00 to 8:30 p.m. The program will be chaired by Patrick I. Borgen, M.D., chair of the department of surgery at Maimonides Medical Center. Borgen will be joined by clinical experts in surgical oncology and anesthesiology who will explore various aspects of contemporary pain management strategies to improve outcomes for patients with breast cancer. To register, click here.
- Coffee Talk: How to Best Apply PARP Inhibition Strategies to Patient Care, which will be held on Friday, March 8, from 7:00 to 8:30 a.m. The program will be chaired by Mark E. Robson, M.D., chief of breast medicine service at Memorial Sloan Kettering Cancer Center. Robson will be joined by leading experts in the management of patients with breast cancer who will address multiple topics pertaining to the use of PARP inhibitors through an engaging and interactive case-based format that will allow for multiple opportunities of audience interaction. To register, click here.
- Meeting Key Unmet Clinical Needs in HER2-Positive Breast Cancer: Aligning the Data With Strategy to Improve Patient Outcomes, which will be held on Saturday, March 9, from 7:00 to 8:30 a.m. The program will be chaired by Debasish Tripathy, M.D., professor and chair in the department of breast medical oncology at The University of Texas MD Anderson Cancer Center. Tripathy will be joined by clinical experts in the management of patients with HER2-positive breast cancer who will review several clinical case scenarios to help contextualize recent evidence regarding the safety and efficacy of different treatment options for patients with early-stage and advanced disease. To register, click here.
Each satellite symposium is accredited by the Accreditation Council for Continuing Medical Education for 1.5 AMA PRA Category 1 Credits™ for physicians.
About Physicians’ Education Resource®
Since 1995, PER® has been dedicated to advancing cancer care through professional education and now furthers patient care and treatment strategies on a wide variety of chronic illnesses and diseases. In 2016, PER® initiated CME programming in the cardiovascular and endocrinology areas. While continuing to expand into topics outside oncology, PER® remains the leading provider of live, online and print CME activities related to oncology and hematology. The high-quality, evidence-based activities feature leading distinguished experts who focus on the application of practice-changing advances. PER® is accredited by the Accreditation Council for Continuing Medical Education and the California Board of Registered Nursing. PER® is part of the Cranbury, New Jersey-based MJH Associates Inc. family of businesses. Learn more at http://www.gotoper.com and http://www.mjhassoc.com.
